iShares Genomics Immunolo... (IDNA)
AMEX: IDNA
· Real-Time Price · USD
22.51
-0.24 (-1.05%)
At close: Sep 10, 2025, 3:59 PM
22.51
0.00%
After-hours: Sep 10, 2025, 06:09 PM EDT
-1.05% (1D)
| Bid | 22 |
| Market Cap | 109.39M |
| AUM | 112.79M |
| NAV | 22.56 |
| EPS (ttm) | 1.26 |
| PE Ratio (ttm) | 17.94 |
| Shares Out | 4.86M |
| Inception Date | Jun 11, 2019 |
| Ask | 23.29 |
| Volume | 47,337 |
| Open | 22.81 |
| Previous Close | 22.75 |
| Day's Range | 22.48 - 22.81 |
| 52-Week Range | 17.26 - 25.80 |
| Holdings | 44 |
| Expense Ratio | 0.47% |
About IDNA
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
Asset Class Equity
Ticker Symbol IDNA
Inception Date Jun 11, 2019
Provider Blackrock
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 40.84% of assets
| Name | Symbol | Weight |
|---|---|---|
| Genmab A/s | GMAB | 4.86% |
| Incyte Corporation | INCY | 4.83% |
| Regeneron Pharmaceut... | REGN | 4.38% |
| Merck & Co., Inc. | MRK | 4.15% |
| Celcuity Inc. | CELC | 4.11% |
| Arcellx, Inc. | ACLX | 4.10% |
| Revolution Medicines... | RVMD | 3.86% |
| Biontech Se | BNTX | 3.65% |
| Moderna, Inc. | MRNA | 3.45% |
| Exelixis, Inc. | EXEL | 3.45% |
Dividends Dividend Yield 1.26%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 16, 2025 | $0.1529 | Jun 20, 2025 |
| Dec 17, 2024 | $0.1110 | Dec 20, 2024 |
| Jun 11, 2024 | $0.1114 | Jun 17, 2024 |
| Dec 20, 2023 | $0.1693 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0708 | Jun 13, 2023 |
